Cell death and the immune response: A lesson from the privileged

Journal of Clinical Immunology

Volumn 17, Issue 1, 1997, Pages 1-10

  Ferguson, Thomas A ^a,b   Griffith, Thomas S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Ophthalmology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAS LIGAND; TUMOR NECROSIS FACTOR ALPHA;

CELL DEATH; EYE; HUMAN; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SERTOLI CELL; TESTIS; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD95; CELL DEATH; EYE; FAS LIGAND PROTEIN; HUMANS; IMMUNE TOLERANCE; LIGANDS; MEMBRANE GLYCOPROTEINS;

EID: 0031050076     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027343210080     Document Type: Review

References (51)

1. Van Dooremaal JC: Die entwickelung der in fremden grund versetzten lebenden gewebe. Albrecht von Graefe's Arch Ophthalmol 19:359-373, 1873
2. Medawar PB: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29:58-69, 1948
3. Greene HSN: Heterologous transplantation of the Brown-Pearce tumor. Cancer Res 9:728-935, 1949
4. Hooper P, Bora N, Kaplan HJ, Ferguson TA: Inhibition of lymphocyte proliferation by resident ocular cells. Curr Eye Res 10:363-372, 1991
5. Wilbanks G, Streilein JW: Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β. Eur J Immunol 22:165-174, 1992
6. Ferguson TA, Fletcher S, Herndon JM. Griffith TS: Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol 155:1746-1756, 1995
7. + cells in the murine iris. Invest Ophthal Vis Sci 32:2423-2431, 1991
8. Bora NS, Kim MC, Kabeer NH, Simpson SC, Tandhasetti MT, Cirrito TP, Kaplan AD, Kaplan HJ: Experimental autoimmune anterior uveitis: Induction with melanin-associated antigen from the iris and ciliary body. Invest Ophthal Vis Sci 36:1056-1066, 1995
9. Apte R, Niederkorn JY: Isolation of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol 156:2667-2673, 1996
10. Ferguson TA, Herndon JM, Dube P: The immune response and the eye. IV. A role for tumor necrosis factor in anterior chamber associated immune deviation. Invest Ophthal Vis Sci 35:2643-2651, 1994
11. Ferguson T, Waldrep JC, Kaplan HJ: The immune response and the eye. II. The nature of T suppressor cell induction in anterior chamber associated immune deviation (ACAID). J Immunol 139: 352-357, 1987
12. Kaplan HJ, Streilein JW: Immune response to immunization via the anterior chamber of the eye: I. F1-lymphocyte induced immune deviation. J Immunol 118:809-814, 1977
13. Sonoda Y, Streilein JW: Impaired cell mediated immunity (ACAID) in mice bearing healthy orthotopic corneal allografts. J Immunol 150:1727-1734, 1993
14. Joo C-K, Pepose JS, Laycock KA, Stuart PM: Allogeneic graft rejection in a murine model of orthotopic comeal transplantation. In Advances in Ocular Immunology, RB Nussenblatt. SM Whitcup, RR Caspi, I Gery (eds). Amsterdam. Elsevier Science B.V. 1994, pp 115-118
15. Whittum-Hudson J, Farazdaghi M, Prendergast RA: A role for T lymphocytes in preventing experimental herpes simplex type 1 retinitis. Invest Ophthal Vis Sci 26:1524-1532, 1985
16. Wetzig RP, Foster S, Greene MI: Ocular immune responses. I. Priming of A/J mice in the anterior with azobenzenearsonate-derivatized cells induces second-order-like suppressor T-cells. J Immunol 128:1753-1759, 1982
17. Niederkorn JY, Streilein JW: Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed type hypersensitivity but normal cytotoxic T lymphocyte responses. J Immunol 131:2587-2594, 1983
18. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192, 1995
19. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 377:630-632, 1995
20. Mogil RJ, Radvanyi L, Gonzalez-Quintial R, Miller R, Mills G, Theofilopoulos A, Green DR: Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo, Int Immunol 7:1451-1458, 1995
21. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365-371, 1994
22. Nagata S, Suda T: Fas and Fas ligand: lpr and gld mutations. Immunol Today 16:39-43, 1995
23. 2+-independent T cell-mediated cytotoxicity. J Exp Med 177:195-200, 1993
24. Abbas, AK: Die and let live: eliminating dangerous lymphocytes. Cell 84:655-657, 1996
25. Nagata S, Golstein P: Fas the death factor. Science 267:1449-1456, 1995
26. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of the fas ligand in cells of T cell lineage. J Immunol 154:3806-3813, 1995
27. Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448, 1995
28. Owen-Schaub LB, Tonehara S, Crump WL, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197-205, 1992
29. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, van Schie R, LaFace D, Green DR: Early redistribution of plasma membrane phosphatidyserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of bcl-2 and abl. J Exp Med 182:1545-1556, 1995
30. Bora NS, Gobelman CL, Atkinson JP, Pepose JS, Kaplan HJ: Differential expression of the complement regulatory proteins in the human eye. Invest Ophthal Vis Sci 34:3579-3584, 1993
31. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S: Fas ligand in human serum. Nature Med 2:317-332, 1996
32. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C, Tschopp J: Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 133:335-343, 1996
33. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubl A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF. Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441-444, 1995
34. Billingham RE, Silvers WK: Studies on cheek pouch skin homografts in the Syrian hamster. Ciba Foundation Symposium on Transplantation, 1962, pp 90-108
35. Lenardo MJ: Interleukin-2 programs mouse αβ T lymphocytes for apoplosis. Nature 353:858-861, 1991
36. Dustin ML, Rothlein R, Bahn AK, Dinurello CA, and Springer TA: Induction by IL-I and interferon-γ: Tissue distribution, biochemistry, function of a natural adherence molecule (ICAM-1). J Immunol 137:245-254, 1986
37. Grell M, Krammer P, Scheurich P: Segregation of APO-1/Fas antigen and tumor necrosis factor receptor mediated apoptosis. Eur J Immunol 24:2563-2566, 1994
38. Um H-D, Orenstein JM, Wahl SM: Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol 156:3469-3477, 1996
39. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA: CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5:7-16, 1996
40. + T cells expressing Vβ8 TCR: A role of the Qa-1 molecule. Immunity 2:185-194, 1995
41. Vandenbark AA, Hashim G, Offner H: Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541-545. 1989
42. Offner H, Hashim GA, Vandenbark AA: T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251:430-433, 1991
43. Griffith TS, Herndon JM, Lima J, Kahn M, Ferguson TA: The immune response and the eye. T-cell receptor α-chain related molecules regulate the systemic immunity to antigen presented via the anterior chamber of the eye. Int Immunol 7:1617-1625, 1995
44. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH: Differential ability of ThI and Th2 T-cells to undergo activation-induced cells death. Int Immunol 6:1545-1553, 1994
45. Thompson CB: Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81:979-982, 1995
46. + type 2 cells. J Exp Med 181:5-7, 1995
47. Lau HT, Yu M, Fontana A, Stoeckert, Jr CJ: Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273:109-112, 1996
48. Stuart PM, Griffith TS, Usui N, Pepose JS, Yu X, Ferguson TA: CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest, in press
49. Brady SE, Rapuano JC, Arentsen JJ, Cohen EJ, Laibson PR: Clinical indications and procedures associated with penetrating keratoplasty. Am J Ophthalmol 108:118-122, 1989
50. Niederkorn JY, Callahan D, Ross JR: Prevention of the induction of allospecific cytotoxic T lymphocyte and delayed hypersensitivity responses by ultraviolet irradiation of corneal allografts. Transplantation 50:281-286, 1990
51. Ferguson TA, Dube P, Griffith TS: Regulation of contact hypersensitivity by IL-10. J Exp Med 179:1597-1603, 1994